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Background: Generalized epileptic convulsions frequently exhibit transient respiratory
symptoms and non-infectious leukocytosis. While these peri-ictal effects appear to arise
independently from one another, the possibility that they stem from a common ictal
pathophysiological response has yet to be explored. We aimed to investigate whether
peri-ictal respiratory symptoms and postictal leukocytosis coexist.
Methods: We performed a single center retrospective chart review of 446 patients
brought to our emergency department between January 1, 2017 and August 23, 2018
for the care of generalized epileptic convulsions with or without status epilepticus. We
included 152 patients who were stratified based on the presence (PeCRC+) or absence
(PeCRC–) of overt periconvulsive respiratory compromise (PeCRC). In addition, patients
were stratified based on the presence or absence of postconvulsive leukocytosis (PoCL),
defined as an initial postconvulsive white blood cell (WBC) count ≥ 11,000 cells/mm3.
Triage vital signs, and chest x ray (CXR) abnormalities were also examined.
Results: Overt PeCRC was observed in 31.6% of patients, 43% of whom required
emergent endotracheal intubations. PoCL was observed in 37.5% of patients, and
was more likely to occur in PeCRC+ than in PeCRC– patients (79.2 vs. 18.2%;
OR = 17.0; 95% CI = 7.2–40.9; p < 0.001). Notably, the magnitude of PoCL was
proportional to the severity of PeCRC, as the postconvulsive WBC count demonstrated
a negative correlation with triage hemoglobin oxygen saturation (R = −0.22; p < 0.01;
CI = −0.48 to −0.07). Moreover, a receiver operating characteristic analysis of the WBC
count’s performance as predictor of endotracheal intubation reached a significant area
under the curve value of 0.81 (95% CI = 0.71–0.90; p < 0.001). Finally, PeCRC+
patients demonstrated frequent CXR abnormalities, and their postconvulsive WBC
counts correlated directly with triage heart rate (R = 0.53; p < 0.001).
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Conclusion: Our data support the existence of an ictal pathophysiological response,
which induces proportional degrees of PoCL and PeCRC. We suggest this response is
at least partially propelled by systemic catecholamines.
Keywords: leukocytosis, respiratory failure, generalized epileptic convulsions, pulmonary edema, neurogenic
pulmonary edema, catecholamines
INTRODUCTION
Sporadically, epileptic seizures are accompanied by a transient
and non-infectious leukocytosis of unclear clinical significance
(1). This phenomenon rarely occurs after self-limiting complex
partial seizures (7%) (1) but it is common after generalized
epileptic convulsions, particularly when they progress into
convulsive status epilepticus (63%) (2). These observations
suggest that postictal WBC counts might be physiologically
linked to the clinical outcomes of different epileptic seizure types.
While the specific factors that induce postconvulsive leukocytosis
(PoCL) remain undefined, a role for systemic catecholamines is
suggested by prior demonstrations that: [1] generalized epileptic
convulsions significantly increase systemic epinephrine and
norepinephrine levels (3–5) and that [2] systemic injections of
catecholamines consistently increase the peripheral white blood
cell (WBC) count (6, 7). At a molecular level, catecholamines
appear to accomplish this effect by disrupting adhesion sites
between WBCs and the endothelium (8). Potential WBC sources
for this response include the lymphatic vessels, spleen, bone
marrow (7) and lungs (9).
Like PoCL, peri-convulsive respiratory compromise (PeCRC)
also occurs across a wide range of epileptic semiologies (10, 11).
It typically manifests itself as transient alterations in respiration
such as apnea, tachypnea, or hypopnea, coupled with decreased
hemoglobin oxygen saturations (SpO2) (10, 11). Further, PeCRC
often demonstrates acute neurogenic pulmonary edema (12, 13),
a potentially lethal condition associated with severe tachycardia
and with a shift of intravascular fluid into the perialveolar
interstitial space and alveoli (14). Acute neurogenic pulmonary
edema has also been associated with postictal leukocytosis (15).
Proposed mechanisms to explain neurogenic pulmonary
edema include inflammatory disruption of the pulmonary
vascular endothelium, ictal negative intrathoracic pressure, and
disruption of the pulmonary endothelial Na/K pump due to
prolonged hypoxia (14). In addition, a leading theory suggests
that neurogenic pulmonary edema is triggered by a massive
increase in systemic catecholamines which causes pulmonary
vasoconstriction and disrupts the capillary-alveolar membrane
(14, 16). Interestingly, neurogenic pulmonary edema appears
to occur more frequently than previously believed (17), and
it is common in convulsive status epilepticus (14, 18). Thus,
it is possible that an unknown fraction of PeCRC cases
relates to the same pathophysiological process which drives
neurogenic pulmonary edema. This notion is supported by
a prior investigation in which 40% of generalized epileptic
convulsions were associated with the development of non-
specific chest x ray (CXR) abnormalities akin to mild pulmonary
edema (19). In this study we sought to investigate the relationship
between PoCL and PeCRC in patients brought to the hospital for
emergent care of generalized epileptic convulsions.
METHODS
Patient Selection and Determination of
PeCRC and PoCL
We performed a retrospective chart review at a large tertiary
care hospital in North Carolina, United States, with approval
from its institutional review board. The study included patients
admitted through our emergency department between January
1, 2017 and August 23, 2018, for the treatment of generalized
epileptic convulsions with impaired awareness, with or without
status epilepticus. For the purposes of this article the word
periconvulsive is meant as the time period that lapses between the
onset of a generalized epileptic convulsion and the postconvulsive
period which precedes a complete return to normal mentation.
We generated a patient source list from electronic medical
records (EMRs) containing ICD-10 codes R56.9 (seizures,
80.4%) and G40.901 (status epilepticus, 19.6%) (n = 446),
regardless of whether or not patients carried a pre-existing
diagnosis of epilepsy. Only EMRs demonstrating unequivocal
written evidence of at least one witnessed generalized epileptic
convulsion occurring immediately prior to arrival at the
emergency department, or inside the emergency department,
were selected for the study. Seventy-three EMRs (i.e., patients)
reflecting convulsive events originally deemed to be epileptic
but later reclassified as syncope, tremor, or other diagnoses,
were excluded from the study. Non-convulsive (n = 101) and
non-epileptic (n = 13) seizure semiologies were also excluded
from the study. In addition, EMRs lacking a postconvulsive
complete blood count drawn within the first 12 h of admission
(CBC1; n= 67), exhibiting evidence of recent or active infections
(n = 26), or the possibility of abnormal immunological function
due to disease (e.g., HIV+ status) or due to active treatment
with chemotherapy, steroids, or other immunosuppressant
agents (n = 14), were also excluded. The remaining EMRs
(n = 152) were separated into two groups depending on
periconvulsive respiratory status. The PeCRC+ group included
EMRs that contained unequivocal written descriptions of
convulsive or postconvulsive respiratory compromise. These
descriptions, as provided by witnesses and medical providers,
included expressions such as “labored breathing,” “cyanosis,”
“became apneic,” “stopped breathing,” “could not breathe,” “was
gasping for air,” and “lips turned blue,” among others. Evidence
of endotracheal intubation was defined as placement of a
tracheal airway followed by a period of mechanical ventilation.
The PeCRC– group included EMRs which did not contain
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such descriptions. EMRs were also stratified according to the
magnitude of the initial postconvulsive WBC count (WBC1)
obtained from CBC1. As previous publications on this subject
have considered postictal leukocytosis as an abnormal elevation
of the WBC count (1, 2), WBC1 counts ≥ 11,000 cells/mm3, the
lowest limit of the abnormal WBC count range at our institution,
were included in the PoCL+ group. Patients with WBC1 counts
≤ 10.900 cells/mm3 were included in the PoCL– group. Initial
postconvulsive hemoglobin, emergency department triage vital
signs, percent SpO2, and the results of initial chest X rays (CXR)
obtained within 36 hours of emergency department triage were
also recorded. Hemoglobin levels were considered abnormally
low when they failed to reach 13.5 g/dL in men, or 12.2 g/dL
in women.
Confirmation of Transient Leukocytosis
By definition PoCL involves a transient elevation of the WBC
count after an epileptic seizure (20). Thus, we controlled for the
effect that non-transient postictal WBC count elevations had on
our results by performing a re-analysis of our data excluding
patients whose WBC1 counts increased on a subsequent CBC
obtained within 36 h of CBC1 (CBC2).
Relative Leukocytosis Index (RLI)
To further examine the relationship between the postconvulsive
WBC count and periconvulsive respiratory symptoms, we
investigated whether minor postconvulsive WBC count
elevations within the boundaries of the normal reference range
also correlated with periconvulsive respiratory status. This
question was assessed by comparing the frequency with which
the WBC count from CBC1 (i.e., WBC1) exceeded the WBC
count from CBC2 (WBC2) in PeCRC+ and PeCRC– patients.
Because none of the patients demonstrated identical WBC
counts in both CBC1 and CBC2, we expected that random
fluctuations of the WBC count would give two equally possible
outcomes: WBC1>WBC2 and WBC2>WBC1. To analyze the
data, we used an arbitrary index, the RLI, which was calculated
as follows: (WBC1–WBC2)/(WBC1). Using this equation, RLIs
> 0 are consistent with the outcomeWBC1>WBC2 and support
the existence of a relative postconvulsive leukocytosis (RPoCL)
response if the WBC1 count < 10.900 cells/mm3, or of a frank
PoCL response if the WBC1 count ≥ 11,000 cells/mm3.
Effect of Hemodilution on Postconvulsive
WBC Counts
Hemodilution from continuous infusion of intravenous fluids in
the hospital can theoretically decrease the WBC2 concentration
and favor an outcome in which WBC1>WBC2. To control for
this factor, we compared the normalized change in WBC count
observed between CBC1 and CBC2, with the corresponding
normalized change in hematocrit between these two samples.
For normalization, the smallest change between CBC1 and CBC2
for each data set was defined as 0%, and the largest change
as 100%.
Quantification of Chest X Ray (CXR)
Abnormalities
To investigate the presence of acute CXR abnormalities in our
cohort, we reviewed available reports of postconvulsive CXRs
acquired no later than 36 h after admission. CXR images were
not reviewed. Patients whose CXR reports suggested chronic
pulmonary pathology (e.g., pulmonary nodules or masses) or
cardiac abnormalities (e.g., cardiomegaly) were excluded from
this part of the analysis. Patients met criteria for the CXR–
(normal) group if their CXR readings denoted unequivocally
normal findings. Such readings included terms such as
“normal,” “nothing acute,” and “no acute cardiopulmonary
disease.” Patients met criteria for the CXR+ (i.e., abnormal)
group if their CXR readings demonstrated any other
findings, including opacities, infiltrates, atelectasis, pulmonary
edema, vascular congestion, pleural effusions, and increased
interstitial markings.
Data Analysis
Continuous variables were compared via parametric or non-
parametric tests based on the presence or absence of a normal
distribution, respectively. Normality was tested by D’Agostino
and Person’s test. Categorical variables were reported as whole
numbers and compared via Fishers exact test, or Chi Square
test for trend as appropriate. Significant associations between
relevant continuous variables were assessed using Pearson
correlation. The frequency of RLIs > 0 was tested using a
binomial test whose null hypothesis assumed equal outcomes
for the relationship between WBC1 and WBC2. Normalized
WBC count changes were compared with their corresponding
normalized hematocrit changes via two-tailedWilcoxonmatched
pairs sign-ranked test. Receiving Operating Characteristic (ROC)
curves were generated to summarize the relationship between
WBC1 count, and heart rate, with endotracheal intubation.
An area under the curve (AUC) value of 0.5 suggests a
predictive performance not different from chance. An AUC
value of 1.0 suggests a predictive performance with 100%
sensitivity and specificity. Statistical significance was defined by
p < 0.05. Prism version 8.0 was used for data analysis and
graph design.
RESULTS
Demographic Characteristics of PeCRC+
and PoCL+ Patients
Age, gender, triage blood pressure, triage temperature, average
blood collection times, average CXR acquisition times, and
average hemoglobin levels were similar across all subgroups
(Table 1). However, CBC1 hemoglobin levels failed to reach
the normal reference range in 39.1% (27/69) of men and
in 32.5% (27/83) of the women included in this study.
PeCRC+ rates were not affected by hemoglobin levels (low
hemoglobin = 31.3%; normal hemoglobin 31.6%; p = 0.86;
Fishers exact test). Triage heart rate, was significantly higher
in PeCRC+ and PoCL+ patients by comparison with PeCRC–
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TABLE 1 | Data and statistics summary for the complete patient cohort.
PeCRC+ PeCRC– p PoCL+ PoCL– p CXR+ CXR– p INT+ INT– p
N (%) 152 (100) 48 (31.6) 104 (68.4) – 57 (37.5) 95 (62.5) – 43 (40.2) 64 (59.8) – 21 (13.8) 131 (86.2) –
PeCRC+ N (%) 48 (31.6) – – – 38 10 *** 25 18 ** – – –
PeCRC– N (%) 104 (68.4) – – – 19 85 18 46 *d – – –
WBC1a 10.2 ± 5.0 14.0 ± 5.0 8.4 ± 3.9 ***d 15.2 ± 4.4 7.2 ± 1.9 ***d 12.0 ± 5.2 10.1 ± 4.9 *d 15.7 ± 6.6 9.3 ± 4.0 ***d
WBC1a <7.9b; N (%) 60 (39.5) 2 58 *** – – – 8 25 * 1 59 ***
WBC1a 7.9–10.5; N (%) 31 (20.4) 7 24 – – – 9 15 3 28
WBC1a 10.6–13.2 N (%) 31 (20.4) 19 12 – – – 15 12 7 24
WBC1a 13.3–31.2N (%) 30 (19.7) 20 10 – – – 11 12 10 20
Hemoglobin (g/dL) 13.1 ± 1.9 13.1 ± 2.3 13.1 ± 1.6 NS 13.2 ± 2.1 13.0 ± 1.7 NS 12.7 ± 2.1 13.2 ± 1.8 NS 13.4 ± 2.3 13.0 ± 1.8 NS
Hours to WBC1 1.1 ± 1.4 1.2 ± 1.5 1.0 ± 1.4 NSd 1.2 ± 1.6 1.0 ± 1.3 NSd 0.9 ± 0.8 1.3 ± 1.5 NSd 1.1 ± 1.0 1.1 ± 1.5 ***d
CXR+ N (%)c 43 (40.2) – – – 24 19 * – – 14 29 **
CXR– N (%)c 64 (59.8) – – – 22 42 – – 7 58
Hours to CXRc 2.9 ± 4.4 2.5 ± 2.8 3.1 ± 5.2 NSd 2.3 ± 2.8 3.4 ± 5.3 NSd 3.2 ± 5.0 2.7 ± 4.0 NSd 2.5 ± 2.8 3.0 ± 4.8 NSd
Age (years) 61.1 ± 18.2 60.5 ± 18.6 61.5 ± 18.1 NS 60.1 ± 17.8 61.8 ± 18.5 NSd 64.7 ± 16.8 63.3 ± 16.6 NS 57.7 ± 13.9 61.7 ± 18.7 NSd
Male 69 (45.4) 22 47 NS 30 39 NS 18 33 NS 8 61 NS
Female 83 (54.6) 26 57 27 56 25 31 13 70
SBP (mm Hg) 147.7 ± 35.7 147.1 ± 41.81 148 ± 32.8 NS 152 ± 40.21 145 ± 30.7 NS 140.3 ± 39.7 153.1 ± 35.4 NS 152 ± 48.6 147 ± 33.4 NS
DBP (mm Hg) 82.2 ± 20.1 81.9 ± 19.8 82.3 ± 20.3 NS 84.1 ± 22.1 81.0 ± 18.9 NS 77.6 ± 21.1 86.2 ± 21.1 * 88.1 ± 22.2 81.2 ± 19.7 *
Heart rate (beats per minute) 99.0 ± 26.9 109.3 ± 28.0 94.3 ± 25.1 *** 110.8 ± 30.2 91.6 ± 22.0 *** 102.4 ± 27.7 99.7 ± 27.0 NS 111.6 ± 33.6 97.0 ± 25.2 *
Temperature (◦F) 98.5 ± 1.2 98.5 ± 28.2 98.4 ± 1.0 NSd 98.6 ± 1.2 98.4 ± 1.2 NS 98.7 ± 1.8 98.4 ± 1.0 NSd 98.7 ± 2.1 98.4 ± 1.0 *d
CXR+ = Abnormal chest X ray; CXR− = Normal chest X ray; DBP = Diastolic blood pressure; INT+ = Intubated; INT− = Not intubated; PeCRC+ = Periconvulsive respiratory compromise; PeCRC− = Absence of periconvulsive
respiratory compromise; PoCL+ = WBC1 count < 11,000 cells/mm3; PoCL− = WBC1 count < 11.000 cells/mm3; SBP = Systolic blood pressure; WBC1 = Initial postictal white blood cell count. Bolded numbers represent discrete
2X2 or 2X4 contingency tables defined by corresponding rows and columns, and analyzed via Fishers exact test or Chi square test for trend, respectively. *** < 0.001; ** < 0.01; * < 0.05. All continuous variables are expressed as mean
± SD. All comparisons were made via two-tailed unpaired Student t-test unless otherwise indicated.
ax103 cells/mm3.
bCombines the two lowest WBC1 quintiles.
cOut of 107 patients whose care included an CXR within 36h of admission.
dComparison via two-tailed Mann Whitney test.
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and PoCL– patients, respectively. A higher triage heart rate
was also seen in INT+ patients by comparison with INT–
patients (Table 1). The average time from triage to CBC1
collection was 1.1 ± 1.4 h (Table 1). The WBC1 count was
significantly higher in PeCRC+, PoCL+, CXR+, and INT+
patients by comparison with PeCRC–, PoCL–, CXR–, and INT–
patients, respectively (Table 1). Forty-eight (31.6%) patients
were PeCRC+, and 21 of these (43.8%) required endotracheal
intubation (INT+). Accordingly, 131 patients did not require
endotracheal intubation (INT–) (Table 1). Relevant clinical
aspects of INT+ patients, as documented in their EMRs, are
described in Table 2. Fifty-seven patients (37.5%) were PoCL+.
PoCL was present in 38 out of 48 PeCRC+ patients (79.2%), but
only in 19 out of 104 (18.2%) PeCRC– patients (OR = 17.0; 95%
CI = 7.2–40.9; Fishers exact test; p < 0.001; Figure 1A; Table 1).
In addition, the WBC1 count of PeCRC+ and PeCRC– patients
exhibited opposite distributions across the cohort’s WBC1 count
range, with the majority of PeCRC+ patients falling in the two
highest quintiles and the majority of PeCRC– patients falling in
the three lowest quintiles (range = 3.3–31.2 cells/mm3; quintile
cutoff values were 6,200; 7,900; 10,500 and 13,200 cells/mm3)
(Figure 1B; Table 1).
Confirmation of Transient Leukocytosis
Of the 152 original EMRs selected for the study, only 107
contained the results of CBC2s collected within 36 h of
CBC1. Average time between CBC1 and CBC2 collection
was 18.4 ± 9.4 h. Two patients from the PoCL+, PeCRC+,
and INT+ groups who demonstrated WBC2 counts that
exceeded their corresponding WBC1 counts were excluded
from this part of the analysis. One patient was excluded from
the INT+ subgroup because his intubation was performed
electively, to facilitate imaging (Table 2). Conclusions and
statistical differences reached from the original 152 patients
(i.e., conclusions drawn from WBC1 alone; Table 1) were
validated in the confirmed leukocytosis analysis, except for
the slightly increased diastolic blood pressure of CXR–
patients, and the minimally elevated diastolic blood pressure
and temperature of INT+ patients (Table 3). While we are
unable to explain the blood pressure differences between these
subgroups, we believe the elevated temperature seen in the
original cohort could stem from undetectable infections in
excluded patients.
PoCL Occurs Most Frequently in PeCRC+
Patients
The WBC1 count of PeCRC+ patients averaged 14.4 ± 5.5 ×
103 cells/mm3 (Figure 1C) and, as expected, demonstrated a
rapid return to the normal reference range (within 17.7 ± 9.7 h
of CBC1; Figure 1C; Table 3). By contrast, while the PeCRC–
group demonstrated WBC1 counts that remained within the
normal reference range, averaging 8.8 ± 4.3 × 103 cells/mm3,
this group also experienced a small but significant WBC count
drop within a similar time frame (within 18.7 ± 9.4 h of
CBC1; Figure 1C; Table 3). These results suggest that a relative
leukocytosis also occurred in patients whose WBC1 counts fell
within the normal reference range. It should be noted that
decreases in WBC count between CBC1 and CBC2 appear to
be unrelated to hemodilution, as they significantly exceeded
corresponding decreases in hematocrit (Figure 1D).
The Majority of Generalized Epileptic
Convulsions Treated in the Emergency
Department Demonstrated Relative
Elevations of the WBC Count
To avoid selection bias, all 107 patients whose EMRs contained
CBC2s collected within 36 h of CBC1 were used for RLI
computations (see below). A large majority of these patients
demonstrated RLIs > 0 (Figure 1E), including patients in the
PoCL– group, whose WBC1 counts by definition fell within
the normal WBC count reference range (65.1% p < 0.001;
Figure 1E). These results indicate that aside from inducing large
PoCL+ responses, generalized epileptic convulsions frequently
induce small WBC count elevations which remain within the
normal reference range (i.e., RPoCL). If these RPoCL responses
are accounted for, PeCRC+ patients demonstrate RLIs > 0 a
notable 89.5% of the time (Figure 1E).
PeCRC Severity Correlates With the
Degree of Triage Heart Rate and WBC1
Count Elevations
PoCL+ and PeCRC+ patients demonstrated increased triage
heart rates by comparison with PoCL– and PeCRC– patients
(Figures 2A,B; Tables 1, 3). In addition the WBC1 count
(Figure 1E) and the triage heart rate (Figure 2C; N = 146
as six patients lacked triage SpO2 data) correlated inversely
with triage SpO2. Notably, this correlation could be detected
despite the widespread delivery of supplemental oxygen to
postconvulsive patients during transport to the emergency
department. Supplemental oxygen data were not available for
every patient, precluding us from drawing further conclusions
about this aspect of our study. Triage heart rate correlated with
theWBC1 count of PeCRC+ patients (pink circles in Figure 2D),
but not with that of PeCRC– patients (orange circles in
Figure 2D). This correlation was particularly significant among
INT+ patients (blue circles in Figure 2D), who additionally
demonstrated augmented WBC1 counts by comparison with
INT– patients (Figure 2E). Moreover, the performance of WBC1
as a predictor of periconvulsive endotracheal intubation analyzed
via ROC yielded an AUC of 0.81 (95% CI = 0.71–0.90; p <
0.001; Figure 2G) with a maximal Youden index J specificity
and sensitivity at a WBC1 cutoff value of 9,200 cells/mm3
(sensitivity 58.02%; specificity 95.24%). A similar analysis of the
relationship between heart rate and intubation yielded an AUC
of 0.64 (Figure 2F).
PeCRC+ Patients Frequently Exhibit
Non-specific CXR Abnormalities
A total of 107 patients from the initial cohort, and 80 patients
from the confirmed leukocytosis subgroup had CXRs performed
within the first 36 h of admission. The average time between
triage and CXR acquisition for each of these groups was 2.9 ±
4.4 and 3.1 ± 4.9 h, respectively. No significant differences in
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TABLE 2 | Clinical characteristics of intubated patients.
INT. LOC. INT. CAUSE BENZOb AEDb SpO2 (%) WBC1
c WBC2c TTE HR CXRd EEGe DX Possible seizure etiologyf
ED RD LOR 2mg NG NA 10.5 8.7 16.2 80 Opacity + SE Posterior Reversible
Encephalopathy
ED RD LOR 4mg LEV 1g 96 10.7 6.1 23.4 96 Atelectasis – SE Brain Metastases
ED RD, AG LOR 8mg NG 93 11.1 5.6 13.4 110 Atelectasis – SE Old subarachnoid
hemorrhage
AH EDa AP LOR 2 mg LEV 1 g NA 12.8 14.8 124.1 70 Atelectasis – SE Severe hyperglycemia,
stroke
EMS RD NG NG 100 12.8 9.0 16.7 94 Pulmonary edema – SE Unclassified epilepsy, not on
AED
AH ED AG LOR 5mg NG 98 9.3 10.7 7.3 100 Atelectasis – GEC Post-stroke epilepsy
ED RD LOR 5mg NG 96 13.0 7.1 12.2 50 Atelectasis – SE Intentional overdosed on
diphenhydramine
ED MS, RD, AG LOR 8mg NG 92 22.0 17.2 17.8 107 Interstitial markings – GEC Unclassified epilepsy
ED RD LOR 2mg NG 97 21.9 16.2 16.6 72 Normal – SE Unclassified epilepsy
ED MS, AP LOR 2mg LEV 1g 91 31.2 16.2 24.8 174 Atelectasis – SE Idiopathic epilepsy,
polysubstance abuse
ED RD NG NG 100 5.0 14.0 62.5 69 Pleural effusion – GEC New intracranial
hemorrhage
ED AP NG NG 98 11.7 11.6 8.0 118 Atelectasis + GEC Post-stroke epilepsy
ED AP LOR 2mg NG 98 21.9 11.3 7.6 136 Normal – SE Unclassified epilepsy
EDa IR LOR 2mg NG 93 9.4 6.8 20.2 110 Normal – GEC New meningitis
ED RD LOR 6mg NG 84 16.5 16.2 32.6 156 Atelectasis – SE Opiate overdose
ED RD, AG LOR 4mg NG 97 11.9 8.8 12.6 126 Normal – GEC Post-stroke epilepsy
ED MS, AP LOR 2mg NG 91 22.8 16.1 40.6 165 Pulmonary edema – SE Idiopathic epilepsy
ED AB LOR 2mg NG 98 28.0 19.1 14.2 142 Normal – SE Idiopathic epilepsy,
medication non-compliance
ED RA LOR 2mg NG 91 15.4 13.7 TRACH 146 Normal – GEC Cerebral palsy
ED RD MID 10mg LEV 1g 95 15.2 12.6 22.8 122 Normal – SE Cerebritis
AH EDa RD LOR 2 mg NG 100 16.1 17.9 5.5 100 Atelectasis – GEC Cocaine
AB, Agonal breathing; AED, Antiepileptic medications; AG, Agitation; AH, Affiliated hospital; AP, Airway protection; BENZO, benzodiazepine; CXR, Chest X ray; DX, Diagnosis; ED,
Emergency department; EEG, electroencephalogram; EEG+, Seizures on EEG; EEG– No seizures on EEG; EMS, Emergency medical services; GEC, Generalized epileptic convulsion;
HR, Heart rate (beats per minute) recorded at ED triage; INT =Intubation; INT LOC, Intubation location; IR, Imaging requirement; LEV, Levetiracetam; LOR, Lorazepam; MID, Midazolam;
MS, Multiple seizures; NA, Not available; NG, None given; RA, Respiratory arrest; RD, Respiratory distress; SpO2, Percent oxygen saturation measured by pulse oximetry at ED triage;
SE, Status epilepticus; TRACH, tracheostomy; TTE, Time to extubation (hours); WBC1, Initial postictal WBC count obtained within 12 h of admission; WBC2, Second postictal WBC
obtained within 36 h of WBC1. Bolded patients were excluded from the confirmed transient leukocytosis reanalysis.
aGrayed, italicized rows represent patients excluded from the confirmatory analysis.
bTotal doses given prior to endotracheal intubation.
c×103 cells/mm3.
dAbnormality reported by reading radiologist.
e+ = seizures; – no seizures, on EEG.
f Inferred from EMR notes and imaging.
CXR acquisition times were detected in subgroup comparisons,
except for CXRs obtained faster for PeCRC+ and PoCL+
patients than for PeCRC– and PoCL– patients in the confirmed
leukocytosis group (p < 0.05; Table 3). We attribute this result
to the urgency of with which physicians order CXRs for patients
who exhibit overt respiratory symptoms. PeCRC+ and PoCL+
patients demonstrated more frequent acute, though non-specific,
CXR abnormalities by comparison with PeCRC– and PoCL–
patients (p< 0.01 and p < 0.05, respectively; Figure 2G;Tables 1,
3). Fifty-eight CXR abnormalities were seen in the entire cohort.
These included opacities (n = 5), infiltrates (n = 13), atelectasis
(n = 21), pulmonary edema (n = 6), vascular congestion
(n = 6), pleural effusions (n = 5), and increased interstitial
markings (n= 2).
DISCUSSION
To our knowledge, this is the first direct investigation of the
relationship between PoCL and PeCRC. Our main finding
is that, in our patient population, the magnitude of the
initial postconvulsive WBC count parallels the severity of
periconvulsive respiratory abnormalities. This was evidenced
by: [1] a high frequency of PoCL in patients who exhibited
PeCRC, and a low frequency of PoCL in patients who did
not exhibit respiratory compromise; [2] an inverse correlation
between the postconvulsive WBC count and the triage SpO2;
[3] a ROC analysis of the WBC1 count’s performance as a
predictor of endotracheal intubation that yielded an AUC of
0.81; and [4] a high frequency of non-specific CXR abnormalities
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FIGURE 1 | Transient leukocytosis coexists with periconvulsive respiratory pathology. (A) PoCL+, WBC1 count ≥ 11 × 103 cells/mm3; PoCL–, WBC1 count < 11 ×
103 cells/mm3; PeCRC+, periconvulsive respiratory compromise. PCRC–, absence of PeCRC; (B) The <7.9 bars include the lowest two WBC1 quintiles (range
3.3–31.2 × 103 cells/mm3 ). (C) Average WBC1 and WBC2 were drawn within 1.1 ± 1.6 h of triage and within 18.4 ± 9.4 h of WBC1, respectively. (D) Normalized
percent change between CBC1 and CBC2 for each data set; Statistical analysis via two-tailed Wilcoxon matched pairs sign-ranked test. HCT, hematocrit; WBC,
White blood cell count. (E) RLI, WBC1–WBC2/WBC1; p-values show the significance of a binomial test comparing the observed frequency of RLI > 0 for each group
against an expected frequency of 50%; (F) SpO2, triage percent oxygen saturation measured by pulse oximetry (N = 146); analyzed via Pearson correlation. All error
bars represent the mean ± s.e.m. ***p < 0.001. Graphs C-E stem from the confirmed transient leucocytosis cohort.
in PoCL+ and PeCRC+ patients. While prior reports had
documented leukocytosis in a majority of patients diagnosed
with convulsive status epilepticus (2, 21), those reports did
not examine the relationship between patients’ postconvulsive
WBC counts and their periconvulsive respiratory symptoms.
Therefore, our work serves as the first direct evidence of a
pathophysiological link between these two seemingly unrelated
periconvulsive epiphenomena.
Surprisingly, the majority of patients included in this study
demonstrated transient postconvulsive WBC count elevations,
regardless of their periconvulsive respiratory status. However,
the scale of these elevations was proportional to associated
respiratory symptoms and was highest, and most frequent, in
the PeCRC+ group. Along with the inverse correlation between
the initial postconvulsive WBC count and the triage SpO2,
this result points to the existence of a pathological gradient
by which the magnitude of the postconvulsive WBC count
mirrors the severity of periconvulsive respiratory symptoms.
This notion is best exemplified by two observations from this
study: Only one out of the 75 (1.3%) patients in the entire
cohort whose postconvulsive WBC counts failed to reach 9,000
cells/mm3 required endotracheal intubation. By contrast six
out of the seven (85.7%) patients in the entire cohort whose
WBC1 counts exceeded 21,000 cells/mm3 required endotracheal
intubation. As the triage heart rate paralleled the initial
postconvulsive WBC count exclusively in PeCRC+ patients, it is
reasonable to hypothesize that both WBC count elevations and
periconvulsive respiratory symptoms resulted from a common
pathophysiological response driven, at least in part, by systemic
catecholamines. Such a response might resemble that which
has been partially attributed to catecholamines in neurogenic
pulmonary edema (14, 18), namely [1] a net augmentation
of the amount of blood flowing through the pulmonary
blood vessels—either because of an increase in heart rate
and cardiac output, or because of a temporary hindrance
of the left ventricular function—and [2] a simultaneous
vasoconstrictive effect on pulmonary blood vessels. Together,
these catecholaminergic effects could increase capillary pressure
and precipitate transvascular fluid filtration into the capillary-
alveolar membrane and alveoli (14, 18, 22). As neurogenic
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TABLE 3 | Data and statistics summary for the confirmed transient PoCL patient subgroup.
PeCRC+ PeCRC– p PoCL+ PoCL– p CXR+ CXR– p INT+ INT– p
N (%) 105 (100) 36 69 – 42 63 35 45 18 87
PeCRC+ N (%) 36 (33.9) – – – 29 7 *** 21 14 ** – – N/A
PeCRC– N (%) 69 (66.1) – – – 13 56 12 31 – –
WBC1a 10.2 ± 5.0 14.4 ± 5.5 8.8 ± 4.3 ***d 15.9 ± 4.9 7.3 ± 1.9 ***d 12.3 ± 5.4 11.1 ± 5.3 NSd 16.2 ± 7.0 9.6 ± 4.3 ***d
Hours to WBC1 1.1 ± 1.6 1.2 ± 1.7 1.1 ± 1.6 NSd 1.3 ± 1.8 1.0 ± 1.5 NSd 0.9 ± 0.8 1.4 ± 1.8 NSd 1.1 ± 1.1 1.1 ± 1.7 NSd
WBC2a 8.4 ± 3.5 10.5 ± 3.6 7.3 ± 2.9 ***d 10.6 ± 3.7 6.9 ± 2.4 ***d 9.6 ± 3.9 8.2 ± 3.7 NSd 12.2 ± 4.1 7.6 ± 2.8 ***d
Hours from WBC1 to WBC2 18.4 ± 9.4 17.7 ± 9.7 18.7 ± 9.4 NSd 20.2 ± 10.4 17.1 ± 8.6 NSd 19.2 ± 9.6 16.4 ± 8.7 NS 15.9 ± 11.1 18.9 ± 9.1 NSd
WBC1a <7.9b; N (%) 36 (34.3) 1 36 *** 0 36 N/A 6 14 NS 1 35 ***
WBC1a 7.9–10.5; N (%) 24 (22.9) 5 18 0 24 6 11 3 22
WBC1a 10.6–13.2; N (%) 20 (19.0) 15 6 18 3 14 8 5 15
WBC1a 13.3–31.2; N (%) 25 (23.8) 15 9 24 0 9 12 9 15
Hemoglobin (g/dL) 13.1 ± 1.8 13.1 ± 2.1 13.1 ± 1.7 NS 13.3 ± 1.9 13.0 ± 1.9 NS 12.7 ± 2.0 13.4 ± 1.9 NS 13.1 ± 2.2 13.1 ± 1.8 NS
CXR+ N (%)c 35 (43.7) – – – 19 14 NS – – – 12 21 *
CXR– N (%)c 45 (56.3) – – 19 26 – – 6 39
Hours to CXRc 3.1 ± 4.9 2.2 ± 2.4 3.7 ± 6.2 *d 2.0 ± 2.4d 4.0 ± 6.3d *d 3.7 ± 5.4 3.1 ± 4.9 NSd 1.8 ± 1.4d 3.4 ± 5.5d NSd
Age (years) 61.1 ± 18.2 60.9 ± 17.8 60.5 ± 16.9 NS 61.3 ± 16.9 60.1 ± 17.4 NS 64.7 ± 17.3 60.6 ± 16.2 NS 58.6 ± 13.2 61.0 ± 17.9 NS
Male N (%) 47 (44.8) 15 32 NS 21 26 NS 14 23 NS 7 40 NS
Female N (%) 58 (55.2) 21 37 21 37 22 22 11 47
SBP (mm Hg) 147.7 ± 35.7 146.3 ± 44.0 146.5 ± 34.9 NS 153.0 ± 41.8 142.5 ± 35.02 NS 143.3 ± 42.0 147.7 ± 35.2 NS 153.9 ± 51.4 145.2 ± 34.9 NS
DBP (mm Hg) 82.2 ± 20.1 82.9 ± 20.6 82.1 ± 32.3 NS 85.9 ± 23.1 80.0 ± 20.5 NS 79.1 ± 21.9 85.8 ± 22.0 NS 89.9 ± 23.4 80.8 ± 21.1 NS
HR (beats per minute) 98.9 ± 26.9 114.8 ± 28.4 96.0 ± 27.1 *** 115.1 ± 31.7 93.9 ± 23.8 *** 105.3 ± 29.0 102.9 ± 28.3 NS 114.6 ± 34.7 99.9 ± 27.0 *
Temperature (◦F) 98.4 ± 1.2 98.6 ± 1.7 98.6 ± 1.2 NSd 98.6 ± 1.3 98.5 ± 1.5 NS 98.8 ± 1.9 98.4 ± 1.1 NSd 98.6 ± 2.2 98.5 ± 1.2 NSd
CXR+ = Abnormal chest X ray; CXR− = Normal chest X ray; DBP = Diastolic blood pressure; INT+ = Intubated; INT− = Not intubated; PeCRC+ = Periconvulsive respiratory compromise; PeCRC− = Absence of periconvulsive
respiratory compromise; PoCL+ = WBC1 count < 11,000 cells/mm3; PoCL− = WBC1 count < 11.000 cells/mm3; SBP = Systolic blood pressure; WBC1 = Initial postictal white blood cell count; WBC2 = Second WBC measured
within 36h of WBC1. Bolded numbers represent discrete 2X2 or 2X4 contingency tables defined by corresponding rows and columns, and analyzed via Fishers exact test, or Chi square test for trend, respectively; p values *** < 0.001;
** < 0.01; * < 0.05; All continuous variables are reported as mean SD. All comparisons were made via two tailed unpaired Student t-test unless indicated otherwise.
ax 103 cells/mm3.
bCombines the two lowest WBC1 quintiles.
cOut of 80 patients whose care included a CXR obtained within 36h of admission.
dCompared via two-tailed Mann Whitney test.
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Vega et al. Significance of Postconvulsive Leukocytosis
FIGURE 2 | Leukocyte and heart rate elevations mirror periconvulsive respiratory pathology. (A) PoCL–, WBC1 count < 11 × 103 cells/mm3; PoCL+, WBC1 count ≥
11 × 103 cells/mm3; bpm, beats per minute. (B) PeCRC–, Absence of periconvulsive respiratory compromise; PeCRC+, Presence of PeCRC. (C) SpO2, Triage
percent oxygen saturation measured by pulse oximetry (N = 146); Analyzed via Pearson correlation. (D) Orange circles, PeCRC– (N = 104); Pink circles, PeCRC+
(N = 48); Blue circles, PeCRC+ INT+ (N = 21); Analysis via Pearson correlation test. (E) INT–, Not intubated; INT+, Intubated; Analysis via Mann-Whitney test. Error
bars show mean ± s.e.m. (F) CXR+, abnormal chest x ray; CXR–, normal chest x-ray; OR = 3.5; 95% CI = 1.5–8.0; p < 0.01; Fishers exact test. (G) AUC obtained
from ROC analysis of WBC1 (blue circles) and heart rate (empty circles) performance as predictors of endotracheal intubation (i.e., respiratory failure). ***p < 0.001. All
graphs represent data obtained from the original GEC cohort.
pulmonary edema has been associated with both, WBC count
elevations and significant CXR abnormalities (14, 15, 18, 23), it
is also possible that the high frequency of CXR abnormalities
observed in the PeCRC+ group could be at least partially
induced by a similar combination of catecholaminergic effects.
However, despite the resemblance of these results with those of an
earlier report of frequent postictal CXR abnormalities following
generalized epileptic convulsions (19), the diverse CXR findings
reported by our reading radiologists, and the generally poor
sensitivity and specificity of roentgenography prevent us from
drawing concrete conclusions about the etiology of these imaging
results. Consequently, the pathophysiological significance of the
non-specific postconvulsive CXR abnormalities unveiled by our
work awaits further investigation.
While the specific mechanisms responsible for PoCL in
humans have not been thoroughly investigated, systemic
catecholamines are likely to play a significant role. This is
suggested by consistent reports that [1] generalized epileptic
convulsions result in major increases in systemic catecholamines
(3–5) and that [2] exogenous catecholamines induce transient
elevations of theWBC count (24, 25). In addition, some evidence
suggests that catecholamine-induced WBC count elevations
result from their boosting effects on heart rate and cardiac output.
For instance, a prior investigation of healthy patients found a
direct correlation between resting heart rate and peripheral WBC
count (26). Similarly, the increased cardiac output that results
from prolonged exhalations, or from deep inhalations against a
closed glottis (i.e., the Muller maneuver) is accompanied by a
rapid elevation of the peripheral WBC count (27). Comparable
elevations in the peripheral WBC count have been induced in
experimental animals by boosting the cardiac output (28). As
the number of marginated leukocytes which resides inside the
pulmonary capillary network more than doubles that of all other
organs combined (29), some investigators have proposed that
transient WBC count elevations seen during states of increased
cardiac output are a direct result of augmented pulmonary blood
flow (28). In the aggregate, these data suggest that systemic
catecholamines play at least a partial role in the induction of both,
PoCL and PeCRC.
In light of the above data, the etiology of respiratory
abnormalities treated by endotracheal intubation in the
periconvulsive period deserves reexamination. Typically,
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generalized epileptic convulsions result in endotracheal
intubation when a high risk of aspiration of oropharyngeal
contents, of accidental airway obstruction, or of respiratory
suppression from aggressive antiepileptic medication doses is
considered imminent (i.e., airway protection) (30). However, as
aspiration pneumonia rarely occurs in the postconvulsive period
(31), and as respiratory suppression is less likely to occur in
generalized epileptic convulsions treated with benzodiazepines
than in those treated with placebo (32), the underlying cause
of the respiratory symptoms that triggers these endotracheal
intubations remains unexplained. In our study, only two of 18
intubations in the confirmed PoCL group intended to protect
the airway. Of the remaining sixteen, five of the six patients
with the highest postconvulsive WBC counts (range 21.9–31.2
cells/mm3) received a total of 2mg of lorazepam or less prior
to intubation. As this low benzodiazepine dose is unlikely to
have suppressed their respiratory drives, respiratory symptoms
in these patients could stem from alternative causes, such
as prolonged central apnea from inefficient contractions of
respiratory muscles (e.g., diaphragm, intercostals, etc.). However,
two prior investigations found no correlation between convulsive
duration and postconvulsive WBC counts (20, 33), suggesting
that the duration of a convulsion alone cannot explain the
coexistence of PoCL and PeCRC in our patients. We hypothesize
that a significant fraction of the endotracheal intubations
performed in our patients addressed the pulmonary effects of
a cardiopulmonary process which simultaneously causes both
PeCRC and PoCL. We further hypothesize that this process is at
least partially driven by systemic catecholamines.
The results of this investigation are consistent with previously
published rates of periconvulsive respiratory anomalies (34),
postictal leukocytosis (1, 2), periconvulsive endotracheal
intubations (30), and postconvulsive CXR findings (19).
Moreover, our results revealed a high incidence of anemia in our
study population, a finding reminiscent of a previously reported
negative correlation between the frequency of epileptic seizures
and hemoglobin levels (35). However, our conclusions are limited
by several factors. First, our study was focused on generalized
epileptic convulsions severe enough to require emergent medical
attention, and therefore our conclusions cannot be generalized
to the overwhelming majority of epileptic convulsions. Second,
our inclusion criteria for the PeCRC+ group could have been
affected by subjective interpretations of patients’ respiratory
signs and symptoms, and by unintentional omissions of these
interpretations from patients’ charts. Third, our data cannot
be used to discriminate central, peripheral, ictal, and postictal
causes of respiratory compromise, which limits our ability to
determine the actual causes of PeCRC in our cohort. Fourth,
while the RLI suggests that WBC count elevations of different
degrees are the norm following generalized epileptic convulsions,
this indirect measure of relative leukocytosis assumes random
fluctuations of the WBC count between the first and the
second CBCs drawn during a patient’s hospital stay. However,
despite concurrent hematocrit data suggesting that WBC count
reductions between these two CBCs occurred independently of
dilutional causes, the WBC count could theoretically also be
affected by blood draws, medications, undetectable infections,
and other unanticipated causes. Finally, it is possible that a
fraction of the CXR abnormalities observed in this study were
induced by undiagnosed aspiration pneumonia. However, the
fleeting nature of accompanying leukocytosis, and the infrequent
incidence of aspiration pneumonia following generalized
epileptic convulsions (31) make this an unlikely possibility.
Despite these limitations, and irrespective of whether the
pathophysiological mechanisms we have proposed are correct,
the relationship between the postconvulsive WBC count and the
severity of periconvulsive respiratory symptoms demonstrated
by our work deserves further exploration. On a practical level,
our results suggest that the postconvulsive WBC count could
be used as a marker for the pathophysiological process, or
processes, by which generalized epileptic convulsions induce
respiratory symptoms in the periconvulsive period. As such,
the postconvulsive WBC count has the potential to become an
important factor in the search for the mechanisms by which
generalized epileptic convulsions result in sudden unexpected
death in epilepsy (SUDEP) as the overwhelming majority of
SUDEP cases demonstrate PeCRC prior to death, and SUDEP
autopsies frequently reveal pulmonary edema, and/or pulmonary
hemorrhages (36).
CONCLUSION
Our work shows, for the first time, that the magnitude of
postconvulsive WBC count elevations corresponds to the
severity of periconvulsive respiratory symptoms. As such,
the postconvulsive WBC count should be considered as
a possible marker for the pathophysiological mechanisms
by which respiration is impaired during generalized
epileptic convulsions.
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